| GTO ID | GTC2993 |
| Trial ID | NCT05332054 |
| Disease | Lymphoma | B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Hematologic Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Recruitment status | Recruiting |
| Title | CB-Long-Term Safety Study (CB-LTSS) |
| Year | 2022 |
| Country | United States |
| Company sponsor | Caribou Biosciences, Inc. |
| Other ID(s) | CB-LTSS |
| Cohort 1 | |||||||||
|
|||||||||